Descriptive Epidemiology of Major Depression in Canada

Abstract

French

Objective:

The Canadian Community Health Survey: Mental Health and Well-Being (CCHS 1.2) is the first national study to use a full version of the Composite International Diagnostic Interview. For this reason, and because of its large sample size, the CCHS 1.2 is capable of providing the best currently available description of major depression epidemiology in Canada. Using the CCHS 1.2 data, our study aimed to describe the epidemiology of major depression in Canada.

Method:

All estimates used appropriate sampling weights and bootstrap variance estimation procedures. The analysis consisted of estimating proportions supplemented by logistic regression modelling.

Results:

The lifetime prevalence of major depressive episode was 12.2%. Past-year episodes were reported by 4.8% of the sample; 1.8% reported an episode in the past 30 days. As expected, major depression was more common in women than in men, but the difference became smaller with advancing age. The peak annual prevalence occurred in the group aged 15 to 25 years. The prevalence of major depression was not related to level of education but was related to having a chronic medical condition, to unemployment, and to income. Married people had the lowest prevalence, but the effect of marital status changed with age. Logistic regression analysis suggested that the annual prevalence may increase with age in men who never married.

Conclusions:

The prevalence of major depression in the CCHS 1.2 was slightly lower than that reported in the US and comparable to pan-European estimates. The pattern of association with demographic and clinical variables, however, is broadly similar. An increasing prevalence with age in single (never-married) men was an unexpected finding.

Keywords

major depression depressive disorder cross-sectional studies prevalence epidemiology

References

Spaner

Bland

Newman

. Major depressive disorder. Acta Psychiatr Scand 1994;Suppl 376:7–15.

Offord

Boyle

Campbell

Goering

Lin

Wong

, and others. One year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry 1996;41:559–63.

Beaudet

. Depression. Health Reports 1996;7(4):11–24.

Beaudet

. Psychological health–depression. Health Reports 1999;11:63–75.

Patten

. Major depression incidence in Canada. CMAJ 2000;163:714–5.

Kessler

Andrews

Mroczek

Ustun

Wittchen

. The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). Int J Methods Psychiatr Res 1998;7:171–85.

Kessler

Ustun

. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004;13:83–121.

SAS Institute Inc [computer program]. Version 8.1. Cary, (NC): The SAS Institute Inc; 2000.

American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM-IV-TR). Washington (DC): American Psychiatric Association; 2000.

10.

Wilkins

Bipolar I disorder, social support and work. Health Reports 2004;Suppl 15:21–30.

11.

Waraich

Goldner

Somers

Hsu

Prevalence and incidence studies of mood disorders: A systematic review of the literature. Can J Psychiatry 2004;49:124–38.

12.

ESEMeD/MHEDEA 2000 Investigators. Prevalence of mental disorders in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004;109(420 Suppl):21–7.

13.

Kessler

Rubinow

Holmes

Abelson

Zhao

The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 1997;27:1079–89.

14.

Szadoczky

Papp

Vitrai

Rihmer

Furedi

The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiological survey. J Affect Disord 1998;50:153–62.

15.

Kessler

Berglund

Demler

Jin

Koretz

Merikangas

, and others. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–105.

16.

Bebbington

Dunn

Jenkins

Lewis

Brugha

Farrell

, and others. The influence of age and sex on the prevalence of depressive conditions: Report from the National Survey of Psychiatric Morbidity. Psychol Med 1998;28:9–19.

17.

Cairney

Wade

. The influence of age on gender differences in depression. Further population-based evidence on the relationship between menopause and the sex difference in depression. Soc Psychiatry Psychiatr Epidemiol 2002;37:401–8.

18.

Kleinbaum

Kupper

Morgenstern

Information bias. Epidemiologic Research. New York (NY): Van Nostrand Reinhold; 1982. p 220–41.

19.

Nightingale

Holmes

Mason

House

Psychiatric illness and mortality after hip fracture. Lancet 2001;357:1264–5.

20.

Watson

Haviland

Greer

Davidson

Bliss

. Influence of psychological response on survival in breast cancer: A population-based cohort study. Lancet 1999;354:1331–6.

21.

Goodwin

Zhang

Ostir

. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc 2004;52:106–11.

22.

Capuron

Ravaud

Gualde

Bosmans

Dantzer

Maes

, and others. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 2001 Nov;26:797–808.

23.

Blumenthal

Lett

Babyak

White

Smith

Mark

, and others. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003;362:604–9.

24.

Lesperance

Frasure-Smith

Talajic

Major depression before and after myocardial infarction: Its nature and consequences. Psychosom Med 1996;58:99–110.

25.

Faris

Purcell

Henein

Coats

AJS

. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur Heart J 2002;4:541–51.

26.

Bush

Ziegelstein

Tayback

Richter

Stevens

Zahalsky

, and others. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001;88:341.

27.

Carney

Freedland

Eisen

Rich

Jaffe

. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995;14(1):88–90.

28.

Mohr

Goodkin

Likosky

Gatto

Baumann

Rudick

. Treatment of depression improves adherence to interferon β-1b therapy for multiple sclerosis. Arch Neurol 1997;54:531–3.

29.

Ciechanowski

Katon

Russo

. Depression and diabetes. Impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278–85.

30.

Singh

Squier

Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. Aids Care 1996;8:261–9.

31.

Ramasubbu

Robinson

Flint

Kosier

Price

. Functional impairment associated with acute poststroke depression: The Stroke Data Bank Study. J Neuropsychiatry Clin Neurosci 1998;10:26–33.

32.

Hotopf

Mayou

Wadsworth

Wessely

Temporal relationships between physical symptoms and psychiatric disorder. Results from a National Birth Cohort. Br J Psychiatry 1998;173:255–61.

33.

Beghi

Roncolato

Vinonà

Depression and altered quality of life in women with epilepsy of childbearing age. Epilepsia 2004;45:64–70.

34.

Boylan

Flint

Labovitz

Jackson

Starner

Devinsky

Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004;62:258–61.

35.

Smith

Gomm

Dickens

. Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliative Medicine 2003;17:509–13.

36.

Janssens

ACJW

van Doorn

de Boer

Kalkers

van der Meché

FGA

Passchier

, and others. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler 2003;9:397–403.

37.

Ruo

Rumsfeld

Hlatky

Liu

Browner

Whooley

. Depressive symptoms and health-related quality of life. The Heart and Soul Study. JAMA 2003;290:215–21.

38.

Benito-León

Morales

Rivera-Navarro

Health-related quality of life and its relationship to cogntive and emotional functioning in multiple sclerosis patients. Eur J Pharmacol 2002;9:497–502.

39.

Fruehwald

Loeffler-Stastka

Eher

Saletu

Baumhackl

Depression and quality of life in multiple sclerosis. Acta Neurol Scand 2001;104:257–61.

40.

Wang

Reimer

Metz

Patten

. Major depression and quality of life in individuals with multiple sclerosis. Int J Psychiatr Med 2000;30:309–17.

41.

Patten

Stuart

Russell

Maxwell

Arboleda-Florez

Epidemiology of depression in a predominantly rural health region. Soc Psychiatry Psychiatr Epidemiol 2003;38:360–5.

42.

Lam

Kennedy

. Prescribing antidepressants for depression in 2005: Recent concerns and recommendations. An addendum to the Canadian Psychiatric Association clinical practice guidelines for treatment of depressive disorders. Can J Psychiatry 2004;49(12) (addendum to Can J Psychiatry 2001;46[suppl 1]): Insert Page1–Insert Page 6.

43.

Andrews

Anstey

Brodaty

Issakidis

Luscombe

Recall of depressive episode 25 yea6rs previously. Psychol Med 1999;29:787–91.

44.

Patten

. Recall bias and major depression lifetime prevalence. Soc Psychiatry Psychiatr Epidemiol 2003;38:290–6.